Stay updated on Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page.

Latest updates to the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page
- Check5 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, signaling a newer build of the site. This appears to be a maintenance update that does not alter the study content or its data on the page.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, representing a deployed update to the ClinicalTrials.gov interface without changing the study information.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page has been updated to a new software/site revision (Revision v3.5.3 instead of v3.5.2). This reflects a version change rather than an update to the clinical study details.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check69 days agoChange DetectedAdded Marinesco-Sjögren syndrome and the Genetic and Rare Diseases Information Center as related resources.SummaryDifference0.2%

- Check84 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page.